Immunotherapy Companies and Organizations

 

148 Organization(s)

3T Biosciences

Business Area(s): 
Description: 

Cancer immunotherapy

Activartis

Business Area(s): 
Description: 

Dendritic Cell-Based Cancer Immunotherapy

Adaptimmune

Business Area(s): 
Description: 

Revolutionizing cancer therapy on a global basis by developing TCR therapies with the potential to treat a wide range of cancer types and patients.

Adheren

Business Area(s): 
Description: 

Cancer immunotherapy

Adicet Bio

Business Area(s): 
Description: 

Working on off-the-shelf cellular therapies that may offer the anticancer efficacy of autologous CAR-T treatments without the logistical complexity. 

Aduro Biotech

Business Area(s): 
Description: 

Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the ...

Advaxis

Business Area(s): 
Description: 

Advaxis’ Lm Technology uses live, attenuated bioengineered Listeria monocytogenes (Lm) bacteria to stimulate the immune system to view tumor cells as potentially ...

Agios Pharmaceuticals

Business Area(s): 
Description: 

Agios works on cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic diseases and metabolic immuno-oncology. 

ALK

Business Area(s): 
Description: 

The company is focused on allergy research, prevention, and diagnosis.

Allergopharma (Merck KgaA)

Business Area(s): 
Description: 

Specific Immunotherapy Allergy Treatment

Alligator Bioscience

Business Area(s): 
Description: 

Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment ...

Alpine Immune Sciences

Business Area(s): 
Description: 

The company creates protein-based immunotherapies to treat cancer, autoimmune disorders, and other diseases.

Amgen

Business Area(s): 
Description: 

Biologics.  Amgen makes several therapeutic drugs that target serious disease.  Many are derived from engineered monoclonal antibodies.  Some target immune receptors.

Aminex Therapeutics

Business Area(s): 
Description: 

Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...

Apitope

Business Area(s): 
Description: 

Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune diseases.

Aptevo Therapeutics

Business Area(s): 
Description: 

Uses modified antibodies to generate immunotherapeutics.

Arcus Biosciences

Business Area(s): 
Description: 

Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.  

ARMO BioSciences

Business Area(s): 
Description: 
Immunotherapies

Ascend Biopharmaceuticals

Business Area(s): 
Description: 
Immunotherapy

AstraZeneca

Business Area(s): 
Description: 

A biopharmaceutical company that focuses on Cardiovascular and Metabolic diseases, Oncology, and Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal diseases, ...

Atara Biotherapeutics

Business Area(s): 
Description: 

Atara Bio’s programs include T-cell product candidates and molecularly-targeted product candidates.

Aurora Biopharma

Business Area(s): 
Description: 
Immunotherapeutic treatments

Avalon GloboCare

Business Area(s): 
Description: 

Avalon GloboCare Corp. is a  healthcare management provider and biotechnology developer, dedicated to integrating and managing global healthcare resources, empowering high-impact biomedical ...

AVM Biotechnology

Business Area(s): 
Description: 

Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative Medicine, CAR-T Immunotherapy & Cancer Treatment.

BeiGene

Business Area(s): 
Description: 

A biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.

Bellicum Pharmaceuticals

Business Area(s): 
Description: 

Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...

BioArctic

Business Area(s): 
Description: 

BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of diseases that affect the Central Nervous System. 

Biocytics

Business Area(s): 
Description: 

Immunotherapy

BioMmune

Business Area(s): 
Description: 
Immunotherapy

Bioscience Vaccines

Business Area(s): 
Description: 
Adjuvant Technology

Biosortia Pharmaceuticals

Business Area(s): 
Description: 

Adjuvants

Bioxyne

Business Area(s): 
Description: 
Immunotherapeutic consisting of inactivated bacteria

Bluebird Bio

Business Area(s): 
Description: 

The cancer immunotherapy research group is focused on the next generation of T cell engineering and creating a pipeline of T cell product candidates (CAR T cells) to treat a wide variety of liquid ...

Bristol-Myers Squibb

Business Area(s): 
Description: 

A biopharmaceutical company.  They discover, develop, and deliver medicines to treat serious disease.

Bullet Biotechnology

Business Area(s): 
Description: 
Immunotherapy

cCAM Biotherapeutics

Business Area(s): 
Description: 
Cancer immunotherapies

Cell Medica

Business Area(s): 
Description: 

Cell Medica develops therapeutics based on cellular immunotherapy with the aim of improving the treatment of cancer and immune reconstitution following hematopoietic stem cell transplant.

Celldex Therapeutics

Business Area(s): 
Description: 

Small Molecules, Biologics, Vaccines, The pipeline is comprised of antibody-based therapies and other protein-based therapeutics that modulate the immune system or directly target tumors.

Cellectis

Business Area(s): 
Description: 

Designing next generation immunotherapies based on gene-edited CAR T-cells

Cellerant Therapeutics

Business Area(s): 
Description: 

Cellerant is developing novel innate and adaptive immunotherapies for oncology and blood-related disorders, including cell-based and antibody therapeutics.

CellSight Technologies

Business Area(s): 
Description: 

CellSight's makes imaging tools to assess the response to immunotherapy..

Checkmate Pharma

Business Area(s): 
Description: 

Develops technology to activate the innate and adaptive arms of the immune system to recognize and ultimately destroy tumor cells.

CiMaas

Business Area(s): 
Description: 
Cellular Immunotherapy

CisThera

Business Area(s): 
Description: 

CisThera’s mission is to develop innovative therapeutics to treat  cancer, autoimmune diseases, as well as chronic kidney and liver diseases.

Cleveland Biolabs

Business Area(s): 
Description: 

Develops molecules to activate Toll like receptors.  These can be used to stimulate the innate immune system.  

Compugen

Business Area(s): 
Description: 

Compugen, via its wholly-owned subsidiary Compugen USA, Inc., is developing therapeutic antibodies against selected target proteins both for cancer immunotherapy  and antibody-drug conjugate ...

Corvus Pharmaceuticals

Business Area(s): 
Description: 

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel agents that target the immune system to treat patients with cancer. 

Cue BioPharma

Business Area(s): 
Description: 

CytomX Therapeutics

Business Area(s): 
Description: 

Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics and ProCAR-NK cell therapies based on Protease-Activated Antibodies, 'Probodies'

DBV Technologies

Business Area(s): 
Description: 
Epicutaneous immunotherapy for allergic desensitization

Dendreon

Business Area(s): 
Description: 

Immunotherapy treatment for prostate cancer.

Dracen Pharmaceuticals

Business Area(s): 
Description: 

Develops glutamine antagonists "immune-metabolism" to improve immune responses against cancer tumors. 

Enlivex Therapeutics

Business Area(s): 
Description: 

Enlivex Therapeutics is a clinical-stage company focused on specialized cell immunotherapy. Their intent is to develop and commercialize an allogeneic drug pipeline designed to rebalance all ...

FivePrime

Business Area(s): 
Description: 

Focused on therapies for cancer and inflammatory diseases

FLX Bio

Business Area(s): 
Description: 

Activating the immune system to eradicate cancer.  Focuses on regulatory T cells.

Forty Seven

Business Area(s): 
Description: 

Committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.

Geneius Biotechnology

Business Area(s): 
Description: 

Immuno-oncology targeting

Genenta Science

Business Area(s): 
Description: 

Genenta is developing a gene transfer strategy into hematopoietic cells to target a specific anti-tumor protein. A disabled virus vector delivers the gene into the cells. A combination of ...

Genexine

Business Area(s): 
Description: 

Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next generation novel long-acting biologics

Don't see an employer? Please fill out the form